Maintenance: On Thursday, June 28 2018, 18:00-18:15, maintenance work on the ZORA servers is scheduled. ZORA will not be available during this period. Thank you for your patience.
Andus, T; Kocjan, A; Müser, M; Baranovsky, A; Mikhailova, T L; Zvyagintseva, T D; Dorofeyev, A E; Lozynskyy, Y S; Cascorbi, I; Stolte, M; Vieth, M; Dilger, K; Mohrbacher, R; Greinwald, R (2010). Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis. Inflammatory Bowel Diseases, 16(11):1947-1956.